secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2022-08-25T23:59:59+00:00
Accession:  0001437749-22-021345
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart appoints Elaine J. Heron to Board; Julie Cherrington resigns
-------------------------------------------------------------------

- Julie Cherrington, Ph.D. resigned from Vaxart Board effective August 25, 2022.
- Elaine J. Heron, Ph.D. appointed to Board, will serve on Audit and Science & Technology Committees.
- Dr. Heron is independent; also serves on boards of BioMarin, Palvella, Visgenx, and Watershed Medical.
- Michael J. Finney appointed Chair of Science & Technology Committee; W. Mark Watson to Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774922021345/0001437749-22-021345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774922021345/vxrt20220824_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-021345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer